CD274 and cancer: For example, PD-L1 positive tumours that have a “cold” phenotype45, do not respond to anti-PD-L1 antibody therapy because blockade of the target, although demonstrably present, does not cause effector immune cells to be recruited to the tumour, or to penetrate its mass to the point that they can engage with individual cancer cells.